Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Monthly Communication Reports in the last 6 Months for Innovative Medicines Canada/Médicaments novateurs Canada

Bettina Hamelin, President (Organization)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results null-null of 40

  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Tara Shannon , Assistant Deputy Minister | Environment and Climate Change Canada (ECCC)

    Subject Matter of the communication: Environment, Health, Industry, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Foreign Affairs
    Communication date: 2024-10-16
    Posted date: 2024-11-12
    Communication number: 371-620808 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Luc Thériault, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-10-16
    Posted date: 2024-11-12
    Communication number: 371-620805 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Greg Orencsak, Deputy Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health, Infrastructure, International Trade, Science and Technology, Small Business, Taxation and Finance, Research and Development, Foreign Affairs
    Communication date: 2024-10-15
    Posted date: 2024-11-12
    Communication number: 371-620801 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ben Chin, Senior Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Agriculture, Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-10-07
    Posted date: 2024-11-12
    Communication number: 371-620795 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Celia Lourenco, Associate Assistant Deputy Minister | Health Products and Food Branch | Health Canada (HC)
    • Michelle Boudreau , Associate Assistant Deputy Minister | Health Policy Branch | Health Canada (HC)
    • Greg Orencsak, Deputy Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Constitutional Issues, Consumer Issues, Health, Infrastructure, International Trade, Science and Technology, Small Business, Taxation and Finance, Research and Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2024-10-02
    Posted date: 2024-11-12
    Communication number: 371-620790 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ritu Banerjee, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Infrastructure, International Trade, Science and Technology, Small Business, Taxation and Finance, Research and Development, Foreign Affairs
    Communication date: 2024-09-26
    Posted date: 2024-10-11
    Communication number: 371-616925 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ehsan Naik, Director of Policy | Office of the Minister of Health | Health Canada (HC)
    • Jade Mallette , Director of Parliamentary Affairs | Office of the Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Constitutional Issues, Consumer Issues, Health, Infrastructure, Intellectual Property, International Trade, Science and Technology, Small Business, Taxation and Finance, Research and Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616911 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jessica Fullerton , Senior Policy Advisor | Office of the Minister of Intergovernmental Affairs | Infrastructure Canada (INFC)

    Subject Matter of the communication: Consumer Issues, Health, Industry, Intellectual Property, International Trade, Science and Technology, Small Business, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616901 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Yash Nanda, Deputy Director of Policy to the Deputy Prime Minister and Minister of Finance of Canada | Finance Canada (FIN)

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616885 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Nicholas Kang, Senior Policy Advisor | Policy and Cabinet Affairs | Prime Minister's Office (PMO)

    Subject Matter of the communication: Agriculture, Consumer Issues, Health, Infrastructure, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616884 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Michelle Boudreau, Associate Assistant Deputy Minister | Strategic Policy Branch | Health Canada (HC)
    • Ya'ara Saks, Minister of Mental Health and Addictions, and Associate Minister of Health | House of Commons

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616883 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Mohamed-Iqbal Ravalia, Senator | Senate of Canada

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616880 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Marie-Françoise Mégie, Senator | Senate of Canada

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616877 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Shuvaloy Majumdar, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616874 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Valerie Bradford, Member of Parliament | House of Commons

    Subject Matter of the communication: Constitutional Issues, Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616873 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Tom Kmiec, Member of Parliament | House of Commons

    Subject Matter of the communication: Constitutional Issues, Consumer Issues, Health, Industry, Intellectual Property, International Trade, Science and Technology, Small Business, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616872 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Chandra Arya, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616870 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Earl Dreeshen, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616867 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Corey Tochor, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616863 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jean-Denis Garon, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616861 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Bernard Généreux, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616859 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ritu Banerjee, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Consumer Issues, Health, Infrastructure, Intellectual Property, International Trade, Science and Technology, Small Business, Taxation and Finance, Research and Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2024-09-23
    Posted date: 2024-10-11
    Communication number: 371-616856 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Alison O'Leary, Senior Assistant Deputy Minister | Infrastructure Canada (INFC)
    • Chris Forbes, Deputy Minister of Finance | Finance Canada (FIN)

    Subject Matter of the communication: Agriculture, Consumer Issues, Health, Infrastructure, Intellectual Property, International Trade, Science and Technology, Small Business, Taxation and Finance, Research and Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2024-09-23
    Posted date: 2024-10-11
    Communication number: 371-616845 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Chris Zhou, Acting Director of Policy to the Minister of Small Business | Innovation, Science and Economic Development Canada (ISED)
    • Ajay Rakhra, Senior Advisor, Ontario and Stakeholder Relations to the Minister of Small Business | Innovation, Science and Economic Development Canada (ISED)
    • Christiana Osei, Digital Media and Communications Advisor to Minister of Small Business | Innovation, Science and Economic Development Canada (ISED)
    • Rechie Valdez, Minister of Small Business | House of Commons

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-23
    Posted date: 2024-10-11
    Communication number: 371-616839 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kim Pate, Senator | Senate of Canada

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-23
    Posted date: 2024-10-11
    Communication number: 371-616836 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Peter Fragiskatos, Member of Parliament | House of Commons

    Subject Matter of the communication: Constitutional Issues, Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-23
    Posted date: 2024-10-11
    Communication number: 371-616834 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Francis Scarpaleggia, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Health, Infrastructure, Intellectual Property, International Trade, Science and Technology, Small Business, Taxation and Finance, Research and Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2024-09-23
    Posted date: 2024-10-11
    Communication number: 371-616830 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Matt Jeneroux, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-23
    Posted date: 2024-10-11
    Communication number: 371-616827 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Tony Baldinelli, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-23
    Posted date: 2024-10-11
    Communication number: 371-616824 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Helena Jaczek, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-23
    Posted date: 2024-10-11
    Communication number: 371-616823 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Yasir Naqvi, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-23
    Posted date: 2024-10-11
    Communication number: 371-616822 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Francesco Sorbara, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-23
    Posted date: 2024-10-11
    Communication number: 371-616821 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Adam Chambers, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-09-23
    Posted date: 2024-10-11
    Communication number: 371-616816 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jamie Kippen, Chief of Staff | Minister's Office | Environment and Climate Change Canada (ECCC)

    Subject Matter of the communication: Consumer Issues, Health, Industry, Intellectual Property, International Trade, Science and Technology, Small Business, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-08-13
    Posted date: 2024-09-10
    Communication number: 371-614159 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Harry Orbach-Miller, Policy Advisor and Senior Coordinator | Prime Minister's Office | Prime Minister's Office (PMO)

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-07-24
    Posted date: 2024-08-14
    Communication number: 371-612766 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Mark Holland, Minister of Health | Health Canada (HC)
    • Jade Mallette, Director of Parliamentary Affairs, office of the Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Consumer Issues, Health, Industry, Infrastructure, Intellectual Property, International Trade, Science and Technology, Small Business, Taxation and Finance, Research and Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2024-07-18
    Posted date: 2024-08-14
    Communication number: 371-612762 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Judith Seidman, Senator | Senate of Canada

    Subject Matter of the communication: Consumer Issues, Health, Industry, Intellectual Property, International Trade, Science and Technology, Small Business, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-06-27
    Posted date: 2024-07-08
    Communication number: 371-609748 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Mohamed-Iqbal Ravalia, Senator | Senate of Canada

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-06-19
    Posted date: 2024-07-08
    Communication number: 371-609747 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Gary Vidal, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2024-06-13
    Posted date: 2024-07-08
    Communication number: 371-609746 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rosemary Moodie , Senator | Senate of Canada

    Subject Matter of the communication: Consumer Issues, Health, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Research and Development, Federal-Provincial Relations
    Communication date: 2024-06-12
    Posted date: 2024-07-08
    Communication number: 371-609745 View monthly communication report
Date Modified: